← back to search

Naiheng Hei

Hebei Medical University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Circular RNAs in diseases, Cancer-related molecular mechanisms research, RNA modifications and cancer, and Cancer-related gene regulation.
h-index
5
citations
42
works
10
NIH funding
primary concept
email

Recent publications

E2F1 Promotes the Occurrence of Head and Neck Squamous Cell Carcinoma and Serves as a Prognostic Biomarker
Applied Biochemistry and Biotechnology 2024cited by 2position: middledoi
ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma
Journal of Cancer 2024cited by 2position: middledoi
The role and mechanism of circ‐BNC2 on the malignant progression of oral squamous cell carcinoma
Head & Neck 2023cited by 9position: middledoi
Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression
Functional & Integrative Genomics 2023cited by 8position: firstdoi
LDLR heterozygous deletion reduces hamster testicular cholesterol toxicity via AMPK/Sirt1/PGC-1α pathway
Toxicology Letters 2023cited by 6position: middledoi
The role of long non-coding RNA LINC01296 in oral squamous cell carcinoma: a study based on bioinformatics analysis and <i>in vitro</i> validation
Journal of Cancer 2022cited by 5position: middledoi
High expression of ECT2 and E2F1 is associated with worse clinical manifestations and prognosis in patients with oral squamous cell carcinoma
European Journal of Inflammation 2022cited by 2position: middledoi
Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis
Archives of Oral Biology 2022cited by 1position: firstdoi
Pathological Characteristics of Malformations of Cortical Development in Golden Syrian Hamsters with LDLR Deficiency
Journal of Neuropathology & Experimental Neurology 2021cited by 1position: middledoi
A two‐CpG‐based prognostic signature for oral squamous cell carcinoma overall survival
Journal of Cellular Biochemistry 2018cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shixiong Peng · Xiangyang Hospital of Traditional Chinese Medicine7 papers (2018–2024)Yanping Chen · Guizhou University3 papers (2018–2022) · 3 papers (2022–2024)Lin‐Yu Jin · Hebei Medical University3 papers (2018–2023)Jianguang Zhao · Hebei Medical University3 papers (2018–2022)Zifeng Cui · Hebei Medical University2 papers (2024–2024)Mingzhao Li · North China University of Science and Technology2 papers (2021–2023)Yang Bao · Hebei Medical University2 papers (2022–2023)Kaicheng Yang · Hebei Medical University2 papers (2018–2022)Zifeng Cui · Hebei Medical University2 papers (2018–2023)Yun Bai · North China University of Science and Technology2 papers (2021–2023)He Chen · Hebei Medical University1 papers (2018–2018)Mei Li · Jiangsu University1 papers (2021–2021)Peng Liu · Sun Yat-sen University1 papers (2023–2023)Yanping Chen · Texas A&M Health Science Center1 papers (2022–2022)Pengfei Yin · University of Florida Health1 papers (2021–2021)Qian Yang · Nanjing Agricultural University1 papers (2024–2024)Yinglai Yang · Xingtai People's Hospital1 papers (2022–2022)Xiaohui Dong · Hebei Medical University1 papers (2023–2023)Yingjie Xia · South China Agricultural University1 papers (2023–2023)